HUREL™ Micro Liver Metabolite ID Services
The HUREL Micro Liver platform continues to be the gold standard advanced cell culture model for use in liver [...]
Visikol to present at SELECTBIO’s December 2021 Conference
Visikol's Director of Drug Discovery, Peter Worthington Ph.D., to Present at SELECTBIO's 3D-Cell Culture, Organoids, and Organs-on-Chips Conference [...]
HUREL Models Assist in the Evaluation of Hepatoxicity
Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]